Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch for their minimal invasive Root Preservation Technology (RPT). The Series A1 round for Odne was led by Revere Partners (NY), an independent venture fund providing capital for cutting-edge innovations in oral and systemic health, and NV Capital (LIE), a family-owned venture capital boutique. Dental Innovation Alliance (DIA), Züricher Kantonalbank, Plug&Play, Hatcher, as well as various family offices and angel investors also participated in the investment round. In total, Odne secured CHF 4.8m (USD 5.5m) which will be used to facilitate the launch in the US market following the FDA approval for its OdneFill and OdneCure solution.
Odne was advised by id est avocats (Michel Jaccard and Tristan Gigon) as well as VISCHER AG (Matthias Staehelin (Corporate/M&A) und Timothy Woodtli (Corporate/M&A)).
Author: Matthias Staehelin
Matthias Staehelin
Attorney at Law and Civil Law Notary (BS/BL)
- Partner
- +41 58 211 33 53
- [email protected]
